Suppr超能文献

急性肝炎:补体成分变化的意义

Acute hepatitis: significance of changes in complement components.

作者信息

Charlesworth J A, Lawrence S, Worsdall P A, Roy L P, Boughton C R

出版信息

Clin Exp Immunol. 1977 Jun;28(3):496-501.

Abstract

Serial measurements of complement components were performed in fifty-nine patients with acute, uncomplicated hepatitis and twelve with alcoholic cirrhosis. Thirty-one of the former group had detectable hepatitis B antigen. Abnormal complement profiles were observed in nine patients with hepatitis B and seven with antigen-negative hepatitis. Low levels of C4, C3 and factor B were common in the subjects with cirrhosis and confined to those cases with severe reduction in serum albumin and/or prothrombin index. By contrast, the complement changes in the patients with hepatitis occurred without significant alteration in these parameters; certain subjects also had reduction in C1q and C5 and a significant number had C3d detectable in fresh plasma. The pattern of abnormality suggests predominant involvement of the classical pathway and it is concluded that this results, at least in part, from an immune process evident only in the early clinical phase of hepatitis. Such gross changes in complement are likely to reflect immune-complex activity and it is proposed that these complexes may be important in the clearance of virus material. The data supports a previous suggestion that recovery from acute hepatitis is primarily dependent on host immune competence rather than viral cytotoxicity or generation of immune complexes.

摘要

对59例急性非复杂性肝炎患者和12例酒精性肝硬化患者进行了补体成分的系列测定。前一组中有31例可检测到乙肝抗原。在9例乙肝患者和7例抗原阴性肝炎患者中观察到补体谱异常。肝硬化患者中C4、C3和B因子水平较低,且仅限于血清白蛋白和/或凝血酶原指数严重降低的病例。相比之下,肝炎患者的补体变化在这些参数上无明显改变;部分患者C1q和C5也降低,且相当数量的患者新鲜血浆中可检测到C3d。异常模式提示主要累及经典途径,得出的结论是,这至少部分是由仅在肝炎临床早期才明显的免疫过程导致的。补体的这种显著变化可能反映免疫复合物活性,有人提出这些复合物可能在病毒物质的清除中起重要作用。该数据支持了先前的一项建议,即急性肝炎的恢复主要取决于宿主免疫能力,而非病毒细胞毒性或免疫复合物的产生。

引用本文的文献

3
Immune complexes in human diseases: a review.
Am J Pathol. 1980 Aug;100(2):529-94.
4
Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.
Gastroenterol Jpn. 1980;15(1):27-32. doi: 10.1007/BF02773701.
5
Problems of bacterial infection in patients with liver disease.
Gut. 1987 May;28(5):623-41. doi: 10.1136/gut.28.5.623.
6
Complement levels in patients with hepatic dysfunction.
Dig Dis Sci. 1990 Feb;35(2):231-5. doi: 10.1007/BF01536768.
7
Paediatric Research Society. Plymouth, 15 and 16 September 1978: Abstracts.
Arch Dis Child. 1979 Feb;54(2):160-5. doi: 10.1136/adc.54.2.160.

本文引用的文献

1
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
Anal Biochem. 1965 Feb;10:358-61. doi: 10.1016/0003-2697(65)90278-2.
2
Fatal complications of virus hepatitis in two patients with agammaglobulinemia.
Am J Med. 1960 Nov;29:804-10. doi: 10.1016/0002-9343(60)90114-5.
4
The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies.
N Engl J Med. 1971 Jul 22;285(4):185-9. doi: 10.1056/NEJM197107222850401.
5
Persistence of the serum hepatitis (SH-Australia) antigen for many years.
Nature. 1969 Jul 5;223(5201):81-2. doi: 10.1038/223081a0.
6
Immunochemical quantitation of antigens by single radial immunodiffusion.
Immunochemistry. 1965 Sep;2(3):235-54. doi: 10.1016/0019-2791(65)90004-2.
8
Complement and liver cell function in 53 patients with liver disease.
Am J Med. 1973 Dec;55(6):783-90. doi: 10.1016/0002-9343(73)90259-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验